ClinicalTrials.gg
Sign In

Osteoporosis, Postmenopausal clinical trials

The registry lists 334 studies for Osteoporosis, Postmenopausal across more than 10 countries. 28 are recruiting or about to start. 308 of them are mainly about Osteoporosis, Postmenopausal (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Osteoporosis, Postmenopausal studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
247
Status unknown
32
Recruiting
19
Active, not recruiting
12
Not yet recruiting
8
Withdrawn
7

Phase

Phase 3
74
Phase 4
73
Phase 2
34
Phase 1
24
Early Phase 1
1

Where

United States
106
Poland
36
Spain
26
Canada
26
China
25
Denmark
24

Who runs them

Eli Lilly and Company (25) · Amgen (24) · Hoffmann-La Roche (21) · Massachusetts General Hospital (11) · Sanofi (10) · Organon and Co (9) · Radius Health, Inc. (7) · GlaxoSmithKline (7)

What is being tested here

Drugs under test in Osteoporosis, Postmenopausal studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Denosumab11731
Ibandronic Acid1525
Teriparatide1722
Romosozumab1612
Prune102
Sodium pentaborate pentahydrate101
Triptorelin101
Estradiol101
Testosterone101
Eldecalcitol101

Drug classes tested here SERMs 12 · Statins 3

Coming up

2phase 3 studies under way
15studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 19 Osteoporosis, Postmenopausal studies recruiting now, 8 (42%) set no upper age limit and 7 (37%) stop at 75 or younger. 1 (5%) take children under 18. 17 (89%) are for women only and 0 (0%) for men only; 7 (37%) take healthy volunteers.

Recruiting studies that take each age, of 19
AgeWomenMen
101 (5%)0 (0%)
184 (21%)1 (5%)
304 (21%)1 (5%)
406 (32%)2 (11%)
5018 (95%)2 (11%)
6518 (95%)2 (11%)
7513 (68%)1 (5%)
8512 (63%)1 (5%)

Across all 334 studies, recruiting or not: 24% stop at 75 or younger and 9% at 65; 12% take children; 93% are for women only and 1% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Osteoporosis, Postmenopausal studies take

Of 30 phase 3 interventional studies under Osteoporosis, Postmenopausal, half reached primary completion within 24 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 324 mo20–44 · 30 studies24 mo19–43 · 29 studies—
Phase 434 mo22–66 · 27 studies——
Interventional, no phase17 mo9–34 · 50 studies—16 mo9–34 · 47 studies
Observational34 mo28–65 · 23 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Results posted1

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 334. Browse all 334 → or search them.